Q3 Presentation and Q&A
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
3 Questions
Nov. 10, 2025
How does ViroGates position suPARnostic® relative to the biological clock competitors? What differentiates suPARnostic® as a biomarker for chronic inflammation and biological aging?
Nov. 10, 2025
How do you envision the revenue mix evolving over the next 2–3 years between acute care, research, and longevity segments - and what internal metrics guide your resource allocation between these areas?
Nov. 10, 2025
Could you elaborate on the expected milestones for FDA clearance and EMA compliance under the expanded Sobi partnership? Additionally, what is the anticipated financial or strategic impact in 2026 and beyond once the product receives approval?